DBV Technologies S.A.
DBVT · DBVTF · Biological Products, (No Disgnostic Substances)
Latest available SEC filing: SCHEDULE 13G/A ·
Latest disclosures
-
Form SCHEDULE 13G/A
SEC filing · Filed
-
Mohideen Pharis: Form 4
Insider disclosure · Filed · Report period 29 Jul 2026
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-K/A
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 3
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001613780 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- DBVT on Nasdaq, DBVTF on OTC
- SEC industry group
- Biological Products, (No Disgnostic Substances) (Office of Life Sciences)
- Business address
- 107 Avenue De La Republique, Chatillon
- Incorporated in
- France
- Fiscal year end
- 31 December
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields